Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Zarxio
Zarxio
First-ever bio-generic drug doesn’t help Novartis shares
Marketwatch
Sun, 03/8/15 - 10:20 am
biologics
Novartis
Neupogen
Zarxio
First Copycat Biotech Drug Spurs $250B Obamacare Savings
Forbes
Sat, 03/7/15 - 11:16 am
Zarxio
Novartis
biologics
Amgen
Neupogen
Novartis gets bragging rights on first U.S. biosim. But will its Neupogen copy sell?
Fierce Pharma
Fri, 03/6/15 - 11:27 am
Novartis
Neupogen
Zarxio
biosimilars sector
Novartis wins approval for first U.S. biosimilar drug
Yahoo/Reuters
Fri, 03/6/15 - 10:01 am
Novartis
FDA
Neupogen
Zarxio
Sandoz
Amgen
Sandoz gets ready to make the biosimilar case with oncologists
Medical Marketing and Media
Thu, 01/22/15 - 09:51 am
Sandoz
biosimilars
physicians
oncologists
Neupogen
Zarxio
Novartis
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Harvoni
Viekira Pak
Gilead Sciences
AbbVie
alirocumab
evolocumab
Amgen
Regeneron
Sanofi
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Novartis
CTL019
Zarxio
Pfizer
palbociclib
Saxenda
Trulicity
Afrezza
MannKind
Eli Lilly
Novo Nordisk
LCZ696
Toujeo
Breo Ellipta
GED-0301
Celgene
BiogenIdec
Pages
« first
‹ previous
1
2